Skip to main content
Loading

Prioritizing Alternative Funding Sources

February 11, 2025
Astor
As venture capital remains difficult to reach, the availability of debt financing, royalty financing, family office funding, and other alternative methods, as well as PIPEs for public companies, become more attractive options. This panel of expert deal makers will share lessons learned on prioritizing and pursuing alternative funding sources.​
Moderator
Jeff Raphael, Managing Partner, Life Sciences Strategic Advisory - OmniScope Partners
Speakers
Chris Chen, Partner, Strategic Investment Fund - Gates Foundation
Lucas de Breed, Director, Investments - BrightEdge - American Cancer Society
Daniel Forman, Partner, Capital Markets & Securities - Lowenstein Sandler LLP
Brienne Kugler, Senior Vice President, Research & Investments - Royalty Pharma
Thomas Hoffmann, Head of Institutional Equities & Corporate Access - H.C. Wainwright & Co., LLC
View all 2025 Program
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors